Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Trevor Cummings

Emergency Medicine Grand Rapids, MI Medical Doctor

NPI 1053534735 CMS profile 1219025

100 Michigan St Ne, Grand Rapids, MI 49503

Open in the dashboard

General payments

$597,991

451 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Trevor Cummings of Grand Rapids, MI is reported in the CMS Open Payments database as having received $597,991 across 451 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $86,590 65
2024 General $125,743 80
2023 General $100,569 73
2022 General $113,484 71
2021 General $75,692 46
2020 General $44,830 30
2019 General $51,083 86

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Trevor Cummings
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Trevor Cummings were reported at $86,590. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Trevor Cummings Emergency Medicine median Middle half National median
2019 $51,083 $51 $18–$128 $163
2020 $44,830 $29 $16–$99 $114
2021 $75,692 $40 $18–$124 $132
2022 $113,484 $49 $20–$134 $149
2023 $100,569 $51 $22–$142 $160
2024 $125,743 $52 $22–$150 $164
2025 $86,590 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $385,758 235 payments
  2. Pfizer Inc. $142,453 121 payments
  3. Stryker Corporation $53,209 47 payments
  4. E.R. Squibb & Sons, L.L.C. $15,568 34 payments
  5. AstraZeneca Pharmaceuticals LP $668 7 payments
  6. Penumbra, Inc. $198 4 payments
  7. Portola Pharmaceuticals, Inc. $92 1 payment
  8. BridgeBio Pharma, Inc. $24 1 payment
  9. Vertiflex, Inc. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $265,274 79 payments
  2. Consulting Fee $261,646 57 payments
  3. Travel and Lodging $55,671 106 payments
  4. Food and Beverage $15,399 209 payments
Products named General payments · program years 2019–2025
  1. CT THROMBECTOMY SYSTEM KIT $478,559 222 payments
  2. FLOWTRIEVER CATHETER, S $339,588 269 payments
  3. PAXLOVID $76,398 31 payments
  4. ELIQUIS Cardiovascular;Metabolic Disease $59,038 86 payments
  5. ClotTriever $27,715 19 payments
  6. FlowTriever Venous Thrombectomy $27,715 19 payments
  7. ELIQUIS Cardiovascular $13,790 24 payments
  8. FLOWTRIEVER Inari Medical $969 10 payments
  9. CLOTTRIEVER BOLD CATHETER $320 4 payments
  10. Indigo System $198 4 payments
  11. Other $853 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$20,588

Medicare's payments for the services billed

Medicare patients

1,288

Average age 73

Services billed

1,519

702 women, 586 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Ischemic heart disease 45%
Chronic kidney disease 42%
Depression 41%
Heart failure 40%
Diabetes 38%
Atrial fibrillation 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

451 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Emergency Medicine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record